Fig. 1 · Structure
Documents & Downloads
CP320626
GP Inhibitor
CP320626 is a potent inhibitor of human liver glycogen phosphorylase, with an IC50 value of 205 nM. This compound effectively reduces blood glucose levels in diabetic mice while maintaining stable plasma insulin concentrations. CP320626 serves as a valuable tool for the investigation of type 2 diabetes and its associated metabolic pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 186430-23-9 |
| Applications | GP Inhibitor |
| Formula | C23H23ClFN3O3 |
| Molecular Weight | 443.90 |
| SMILES | O=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=C(F)C=C3)C(N4CCC(O)CC4)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.